当代医学
噹代醫學
당대의학
CHINA CONTEMPORARY MEDICINE
2013年
9期
3-4
,共2页
方浩威%黄晓芸%梅志忠%黄益洪%陈建军
方浩威%黃曉蕓%梅誌忠%黃益洪%陳建軍
방호위%황효예%매지충%황익홍%진건군
超选择性动脉溶栓%静脉溶栓%急性脑梗死
超選擇性動脈溶栓%靜脈溶栓%急性腦梗死
초선택성동맥용전%정맥용전%급성뇌경사
Supperselected intraaterial thrombolysis%Venous thrombolysis%Acute cerebral infarction
目的分析超选择性动脉溶栓与静脉溶栓对老年急性脑梗死的疗效和安全性并进行对比.方法将2010~2012年就诊的63例老年急性脑梗死患者随机分成实验组与对照组,实验组31例,采用尿激酶超选择性动脉溶栓治疗;对照组32例,行静脉溶栓治疗.两组分别于溶栓前和溶栓后的30 min、2 h、12 h、24 h、3 d、7 d、14 d按美国国立卫生院卒中评分(NIHSS)进行神经功能缺损程度评分及按欧洲脑卒中评分标准(ESS)评价治疗效果并统计治愈情况.结果治疗后实验组平均NIHSS评分为(8.7±2.3),对照组为(10.6±2.9),实验组低于对照组(P<0.05);实验组平均ESS评分为(80.79±14.26),对照组平均评分为(72.31±14.13),实验组平均ESS评分显著优于对照组(P<0.05).结论采用尿激酶超选择性动脉溶栓与静脉溶栓都有较好的疗效和安全性,但超选择性动脉溶栓疗法优于静脉溶栓,在临床上具有推广意义.
目的分析超選擇性動脈溶栓與靜脈溶栓對老年急性腦梗死的療效和安全性併進行對比.方法將2010~2012年就診的63例老年急性腦梗死患者隨機分成實驗組與對照組,實驗組31例,採用尿激酶超選擇性動脈溶栓治療;對照組32例,行靜脈溶栓治療.兩組分彆于溶栓前和溶栓後的30 min、2 h、12 h、24 h、3 d、7 d、14 d按美國國立衛生院卒中評分(NIHSS)進行神經功能缺損程度評分及按歐洲腦卒中評分標準(ESS)評價治療效果併統計治愈情況.結果治療後實驗組平均NIHSS評分為(8.7±2.3),對照組為(10.6±2.9),實驗組低于對照組(P<0.05);實驗組平均ESS評分為(80.79±14.26),對照組平均評分為(72.31±14.13),實驗組平均ESS評分顯著優于對照組(P<0.05).結論採用尿激酶超選擇性動脈溶栓與靜脈溶栓都有較好的療效和安全性,但超選擇性動脈溶栓療法優于靜脈溶栓,在臨床上具有推廣意義.
목적분석초선택성동맥용전여정맥용전대노년급성뇌경사적료효화안전성병진행대비.방법장2010~2012년취진적63례노년급성뇌경사환자수궤분성실험조여대조조,실험조31례,채용뇨격매초선택성동맥용전치료;대조조32례,행정맥용전치료.량조분별우용전전화용전후적30 min、2 h、12 h、24 h、3 d、7 d、14 d안미국국립위생원졸중평분(NIHSS)진행신경공능결손정도평분급안구주뇌졸중평분표준(ESS)평개치료효과병통계치유정황.결과치료후실험조평균NIHSS평분위(8.7±2.3),대조조위(10.6±2.9),실험조저우대조조(P<0.05);실험조평균ESS평분위(80.79±14.26),대조조평균평분위(72.31±14.13),실험조평균ESS평분현저우우대조조(P<0.05).결론채용뇨격매초선택성동맥용전여정맥용전도유교호적료효화안전성,단초선택성동맥용전요법우우정맥용전,재림상상구유추엄의의.
@@@@Objective To discuss about the therapeutical effect of supperselected intraaterial thrombolysis and venous thrombolysis treating senile acute cerebral infarction and then make a comparison. Methods Pick up the patients who developed acute cerebral infarction in our from 2010 to 2012, diving them into experimental and control groups randomLy. Control group (32 cases) took the venous thrombolysis, the experimental group (31 cases) took supperselected intraaterial thrombolysis. All the patients are scored by NIHSS and ESS standard before and after their treatment. Results NIHSS score of experimental group (8.7±2.3) was significantly lower than control group (10.6±2.9) ESS score of experimental group (80.79±14.26) was better than control group (72.31±14.13). Conclusion Supperselected intraaterial thrombolysis and venous thrombolysis are both good ways in treating senile acute cerebral infarction, but the supperselected intraaterial thrombolysis is better, providing the meaning for clinical promotion.